A Retrospective Protocol Empowering Precision Research in Colorectal Cancer (ALFAOMEGA-RETRÒ)
Sponsored by IFOM ETS - The AIRC Institute of Molecular Oncology
About this trial
Last updated 2 years ago
Study ID
IFOM-CPO006/2019/PO005
Status
Recruiting
Type
Observational
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Started 5 years ago
What is this trial about?
ALFAOMEGA-RETRÒ will be exploited to retrospectively collect clinical and imaging data and
archival samples to be used for validation and correlative studies on markers discovered by
cutting-edge translational projects within the AIRC5x1000 program "Insights into the evolving
heterogeneity of colorectal cancer (CRC): from mechanism to therapies" (an ongoing
multi-institutional research program).
What are the participation requirements?
Inclusion Criteria
- Histologically-confirmed diagnosis of colorectal cancer (any stage).
- Age >18 years at the time of diagnosis.
- Availability of clinically-annotated radio-imaging data and/or diagnostic Formalin-Fixed Paraffin Embedded (FFPE) blocks (surgical resections and/or tumor biopsies), or at least 10 slides (preferably 20). FFPE tissue blocks are always preferred to slides.
- Verification that the patient could not be reached for informed consent in accordance with applicable national regulations.
Exclusion Criteria
- if inclusion criteria are not met